Publications by authors named "Matthew Eadens"

Claim this Profile
A
A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors.
Tufia Haddad, Rui Qin, Ruth Lupu, Daniel Satele, Matthew Eadens

Cancer Chemother Pharmacol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status of SRC inhibitors in solid tumor malignancies.
Lauren N Puls, Matthew Eadens, Wells Messersmith

Oncologist· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of maintenance treatments for nonsmall cell lung cancer.
Matthew J Eadens, Steven I Robinson, Katharine Ar Price

Lung Cancer (Auckl)· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curable metastatic colorectal cancer.
Matthew J Eadens, Axel Grothey

Curr Oncol Rep· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy for non-small-cell lung carcinoma: from a blanket approach to individual therapy.
Thanyanan Reungwetwattana, Matthew J Eadens, Julian R Molina

Semin Respir Crit Care Med· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2.
Jennifer L Spratlin, Roger B Cohen, Matthew Eadens, Lia Gore, D Ross Camidge

J Clin Oncol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis